Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Nicolas Vignolles"'
Autor:
Gilles Montalescot, Olivier Barthelemy, Claude Le Feuvre, Lee S. Nguyen, Nicolas Vignolles, Jean-Philippe Collet, Johanne Silvain, Vincent Spagnoli, Gérard Helft, Paul Guedeney, Kristel Cosker, Mathieu Kerneis
Publikováno v:
Heart
Heart, 2018, 104 (9), pp.767-772. ⟨10.1136/heartjnl-2017-311975⟩
Heart, 2018, 104 (9), pp.767-772. ⟨10.1136/heartjnl-2017-311975⟩
ObjectivesContrast-induced acute kidney injury (CI-AKI) is a common and potentially severe complication in patients with ST elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (pPCI). There is no consensus
Autor:
Olivier Varenne, Chandrasekaran Nagaswami, Jean-Philippe Collet, Johanne Silvain, Christian Spaulding, Stéphane Manzo-Silberman, Xavier Jouven, Carole Maupain, Chantal M. Boulanger, Delphine Brugier, John W. Weisel, Paul Guedeney, Nicolas Vignolles, Muriel Tafflet, Gilles Montalescot, Jean-Philippe Empana, Mathieu Kerneis
Publikováno v:
Resuscitation
Resuscitation, 2017, ⟨10.1016/j.resuscitation.2017.01.030⟩
Resuscitation, Elsevier, 2017, ⟨10.1016/j.resuscitation.2017.01.030⟩
Resuscitation, Elsevier, 2017, 〈10.1016/j.resuscitation.2017.01.030〉
Resuscitation, 2017, ⟨10.1016/j.resuscitation.2017.01.030⟩
Resuscitation, Elsevier, 2017, ⟨10.1016/j.resuscitation.2017.01.030⟩
Resuscitation, Elsevier, 2017, 〈10.1016/j.resuscitation.2017.01.030〉
International audience; Background and aimIt was hypothesized that the pattern of coronary occlusion (thrombus composition) might contribute to the onset of ventricular arrhythmia and sudden cardiac death (SCD) in myocardial infarction (MI).MethodsTh
Autor:
J P Collet, Paul Guedeney, Stéphanie Rouanet, Mathieu Kerneis, Nicolas Vignolles, Georges Hage, Eric Vicaut, Pavel Overtchouk, Gilles Montalescot, Marie Hauguel-Moreau, J. Silvain, Michel Zeitouni, Delphine Brugier, Holger Thiele, O. Barthelemy
Publikováno v:
European Heart Journal. 40
Background Thrombolysis In Myocardial Infarction (TIMI) flow is a prognostic factor which assessment is complex in life-threatening situations. Because TIMI flow evaluation by site investigator (SI) is subject to bias, independent Core-Laboratory (CL
Autor:
Uwe Zeymer, Mathieu Kerneis, Delphine Brugier, Stéphanie Rouanet, Jean-Philippe Collet, Paul Guedeney, Marie Hauguel-Moreau, Johanne Silvain, Gilles Montalescot, Michel Zeitouni, Steffen Desch, Olivier Barthelemy, Georges Hage, Holger Thiele, Eric Vicaut, Nicolas Vignolles, Pavel Overtchouk
Publikováno v:
Circulation: Cardiovascular Interventions
Circulation: Cardiovascular Interventions, American Heart Association, 2019, 12 (10), pp.e008296. ⟨10.1161/CIRCINTERVENTIONS.119.008296⟩
Circulation: Cardiovascular Interventions, American Heart Association, 2019, 12 (10), pp.e008296. ⟨10.1161/CIRCINTERVENTIONS.119.008296⟩
International audience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5565d18441096960bbdc6fe554f99dad
https://hal.sorbonne-universite.fr/hal-02394297
https://hal.sorbonne-universite.fr/hal-02394297
Autor:
Philippe Cluzel, Philippe Gabriel Steg, Catherine Monnot, Jean Michel Serfaty, Gilles Montalescot, Stéphane Germain, Thomas Mathivet, Elodie Berland, Claire Bouleti, Nicolas Vignolles
Publikováno v:
International Journal of Cardiology
International Journal of Cardiology, Elsevier, 2015, 187, pp.511--516. ⟨10.1016/j.ijcard.2015.03.263⟩
International Journal of Cardiology, 2015, 187, pp.511--516. ⟨10.1016/j.ijcard.2015.03.263⟩
International Journal of Cardiology, Elsevier, 2015, 187, pp.511--516. ⟨10.1016/j.ijcard.2015.03.263⟩
International Journal of Cardiology, 2015, 187, pp.511--516. ⟨10.1016/j.ijcard.2015.03.263⟩
Background No-reflow in ST-segment elevation acute myocardial infarction (STEMI) is associated with a poor clinical prognosis. Its pathophysiological mechanisms are not fully elucidated yet but enhanced vascular permeability plays a key role in this
Autor:
Michel Zeitouni, Maryse Guerin, J. Silvain, Mathieu Kerneis, Gilles Montalescot, B Lattuca, Philippe Lesnik, J P Collet, Nicolas Vignolles, Paul Guedeney
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 11:118
Background Heterozygous Familial Hypercholesterolemia (HeFH) is an underdiagnosed form of dyslipidemia associated with higher risk of myocardial infarction (MI). Identifying patients with possible HeFH would allow family screening and more aggressive
Autor:
David Brieger, Nicolas Vignolles, Anne Bellemain-Appaix, Antoine Landivier, Olivier Barthelemy, Dominique Costagliola, Johanne Silvain, Gilles Montalescot, Anne Mercadier, Jean-Philippe Collet, Farzin Beygui, Rémi Choussat
Publikováno v:
Catheterization and Cardiovascular Interventions. 77:182-190
Objectives: The aim of this study was to compare efficacy and safety outcomes among patients receiving enoxaparin or unfractionated heparin (UFH) while undergoing percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction
Autor:
Johanne Silvain, Jean-Philippe Collet, Ana Pena, Sophie Gallier, Anne Bellemain, Gilles Montalescot, M.L. Tanguy, Farzin Beygui, Nicolas Vignolles, Guillaume Cayla, Antoine Landivier
Publikováno v:
Circulation. 118:1225-1233
Background— Clopidogrel loading has mostly been studied in clopidogrel-naïve patients. Whether clopidogrel-treated patients readmitted for an acute coronary syndrome or percutaneous coronary intervention can benefit from a new load of clopidogrel
Autor:
Olivier Barthelemy, Jean-Jacques Benoliel, Raphaelle Dumaine, Gilles Montalescot, Nicolas Vignolles, Farzin Beygui, Jean-Philippe Collet
Publikováno v:
Circulation. 114:2604-2610
Background— Aldosterone, the final mediator of the renin-angiotensin-aldosterone pathway, is at its highest plasma levels at presentation for ST-elevation myocardial infarction (STEMI). Whether aldosterone level at presentation for STEMI is associa
Autor:
Farzin Beygui, Daniel Thomas, Jean-Philippe Collet, M.L. Tanguy, R. Choussat, G. Montalescot, A. Ankri, Gérard Drobinski, Jean-Louis Golmard, Nicolas Vignolles
Publikováno v:
American Heart Journal. 147:655-661
Subcutaneous enoxaparin during at least 48 hours provides adequate anticoagulation and good clinical results in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention (PCI).In this nonrandomized